Vanguard Asset Management
AZN icon

Vanguard Asset Management’s AstraZeneca AZN Stock Holding History

Vanguard Asset Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.49B Buy
18,712,920
+177,605
+1% +$33.4M 2.36% 6
2026
Q1 		$3.62B Buy
+18,535,315
New +$3.57B 3.1% 4

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $18.4B AUM 23.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Asset Management's AZN Position: Q2 2026 in Review

Vanguard Asset Management increased its AstraZeneca (AZN) stake by 0.96% in Q2 2026, buying an estimated $33.4M and bringing the position to 18,712,920 shares worth $3.49B. The position accounts for 2.36% of the portfolio, ranked #6.

Vanguard Asset Management first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. The position peaked at $3.62B in Q1 2026. 1,425 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Vanguard Asset Management held 18,712,920 shares of AstraZeneca worth $3.49B as of Q2 2026.
  • Vanguard Asset Management bought 177,605 AstraZeneca shares in Q2 2026, an estimated $33.4M.
  • AstraZeneca made up 2.36% of Vanguard Asset Management's portfolio in Q2 2026, its #6 holding.
  • Vanguard Asset Management first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Asset Management's AstraZeneca position peaked at $3.62B in Q1 2026.
  • 1,425 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.